Doximity Change in Accounts Receivable 2020-2025 | DOCS

Doximity change in accounts receivable for the twelve months ending June 30, 2025 was $-0.101B, a 3723.97% decline year-over-year.

  • Doximity annual change in accounts receivable for 2025 was $-0.027B, a 781.34% decline from 2024.
  • Doximity annual change in accounts receivable for 2024 was $0.004B, a 115.22% decline from 2023.
  • Doximity annual change in accounts receivable for 2023 was $-0.026B, a 15.39% decline from 2022.

Doximity Change in Accounts Receivable 2020-2025 | DOCS

  • Doximity annual change in accounts receivable for 2025 was $-0.027B, a 781.34% decline from 2024.
  • Doximity annual change in accounts receivable for 2024 was $0.004B, a 115.22% decline from 2023.
  • Doximity annual change in accounts receivable for 2023 was $-0.026B, a 15.39% decline from 2022.
Related Stocks
Company NameMarket
Cap
Veeva Systems (VEEV)$46.1B
Tempus AI (TEM)$13.3B
Hims & Hers Health (HIMS)$9.9B
IRhythm Technologies (IRTC)$5.4B
Hinge Health (HNGE)$4.4B
Inspire Medical Systems (INSP)$2.7B
Privia Health (PRVA)$2.6B
Heartflow (HTFL)$2.3B
Phreesia (PHR)$1.7B
Enovis (ENOV)$1.7B
10x Genomics (TXG)$1.6B
Omnicell (OMCL)$1.5B
Schrodinger (SDGR)$1.4B
Azenta (AZTA)$1.4B
Clover Health Investments (CLOV)$1.3B
Claritev (CTEV)$1.1B
Evolent Health (EVH)$1B
Fulgent Genetics (FLGT)$655M
Zepp Health (ZEPP)$580M
Veradigm (MDRX)$525M
Standard BioTools (LAB)$458M
Talkspace (TALK)$456M
Butterfly Network (BFLY)$350M
Carlsmed (CARL)$342M
TruBridge (TBRG)$296M
Outset Medical (OM)$243M
SOPHiA GENETICS SA (SOPH)$232M
Nyxoah SA (NYXH)$216M
Health Catalyst (HCAT)$215M
KORU Medical Systems (KRMD)$190M